NASDAQ:AKBA | Profit Margins | Akebia Therapeutics, Inc.

Complete source-backed margin history.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical Profit Margins

DateGross marginOperating marginNet margin
2026-06-30—-12.88%-18.13%
2026-03-31—-8.77%-16.91%
2025-12-31—-14.84%-21.25%
2025-09-30—7.57%0.92%
2025-06-30—22.55%0.40%
2025-03-31—23.57%10.66%
2024-12-31—-30.77%-49.04%
2024-09-30—-33.41%-53.54%
2024-06-30—-19.99%-19.66%
2024-03-31—-45.81%-55.16%
2023-12-31—2.45%1.09%
2023-09-30—-31.00%-34.46%
2023-06-30—-15.96%-19.82%
2023-03-31—-63.98%-67.18%
2022-12-31—-8.73%-10.88%
2022-09-30—-103.47%-111.05%
2022-06-30—26.97%23.30%
2022-03-31—-96.57%-102.93%
2021-12-31—-110.99%-118.58%
2021-09-30—-112.57%-122.13%
2021-06-30—-149.95%-156.93%
2021-03-31—-124.15%-133.03%
2020-12-31—-150.63%-153.44%
2020-09-30—-96.84%-99.95%
2020-06-30—-192.83%-194.97%
2020-03-31—-66.82%-68.66%
2019-12-31—-136.43%-135.84%
2019-09-30—-60.78%-59.35%
2019-06-30—-59.05%-57.71%
2019-03-31—-104.55%-99.66%
2018-12-31—-150.64%-100.34%
2018-09-30—-52.37%-48.99%
2018-06-30—-73.09%-69.82%
2018-03-31—-53.34%-50.99%
2017-12-31—16.13%17.14%
2017-09-30—-58.56%-56.04%
2017-06-30—-77.62%-75.45%
2016-12-31—-2478.44%-2466.58%

Annual Profit Margins

DateGross marginOperating marginNet margin
2025-12-31—9.95%-2.26%
2024-12-31—-31.51%-43.33%
2023-12-31—-23.77%-26.68%
2022-12-31—-27.62%-32.22%
2021-12-31—-124.23%-132.43%
2020-12-31—-127.47%-129.85%
2019-12-31—-85.46%-83.48%
2018-12-31—-85.76%-69.12%
2017-12-31—-42.31%-40.65%
2016-12-31—-8889.90%-8843.45%